Related Experiment Videos
Bone marrow necrosis: an entity often overlooked.
D Maisel1, J Y Lim, W J Pollock
1Department of Pathology, University of South Alabama Medical Center, Mobile 36617.
Annals of Clinical and Laboratory Science
|March 1, 1988
Summary
Bone marrow necrosis, a common finding in biopsies, often links to underlying conditions like cancer or infections. Its severity correlates with patient prognosis, emphasizing the need for clinical context in diagnosis.
Area of Science:
- Hematology
- Pathology
- Oncology
Background:
- Bone marrow necrosis (BMN) is an underrecognized finding in bone marrow biopsies.
- Previous incidence rates vary widely, from 0.5% to 33%.
Purpose of the Study:
- To determine the incidence and clinical significance of BMN in bone marrow biopsies.
- To explore the association between BMN severity and underlying etiologies and patient prognosis.
Main Methods:
- Retrospective analysis of bone marrow biopsies.
- Correlation of BMN presence and grade with clinical data, including patient age, underlying diseases, and outcomes.
Main Results:
- BMN was observed in 37% of examined biopsies.
- Mild, moderate, and severe necrosis occurred in 26.4%, 7.5%, and 3.1% of cases, respectively.
- Identifiable etiologies (malignancy, vascular/cytotoxic damage) were found in most cases; prognosis depended on the primary condition.
Conclusions:
- BMN is a frequent finding influenced by the patient's clinical status.
- BMN grading provides insights into disease severity, but prognosis is primarily dictated by the underlying primary condition.